DC-U4106 | Interleukin Related interleukin-related.com

Product Name :
DC-U4106

Search keywords :
DC-U4106

drugId :
null

Target Vo:
Ubiquitin carboxyl-terminal hydrolase 8

Target Vo Short Name :
USP8

Moa_Name:
Ubiquitin carboxyl-terminal hydrolase 8 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
China Pharmaceutical University

Active Company_Name :
China Pharmaceutical University

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
S100A10 (Y10P93) Mouse mAb Epigenetic Reader Domain
Phospho-AMPK alpha 2(S345) Rabbit mAb Autophagy
c-Rel Antibody: c-Rel Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to c-Rel. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts